Development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study

被引:0
作者
Li, Ying [1 ]
Lai, Xiaorong [1 ]
Yang, Dongyang [1 ]
Ma, Dong [1 ,2 ]
机构
[1] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Departmentof Med Oncol 2, Guangzhou, Peoples R China
[2] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Departmentof Med Oncol 2, 106 Zhongshan 2 Rd, Guangzhou 510000, Guangdong, Peoples R China
关键词
Colon cancer (CC); survival; predictors; nomogram; Surveillance; Epidemiology; and End Results (SEER) database; PROGNOSIS; SURVEILLANCE;
D O I
10.21037/jgo-22-878
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Colon cancer (CC) is the third most commonly diagnosed malignant tumor and remains the second leading cause of cancer-related deaths worldwide. However, the risk assessment of poor prognosis of CC is limited in previous studies. This study aimed to develop a predictive nomogram for the survival of CC patients. Methods: In this retrospective cohort study, 113,239 CC patients from the Surveillance, Epidemiology, and End Results (SEER) database were randomly divided into training (n=56,619) and testing (n=56,620) sets with a ratio of 1:1. Demographic, clinical data and survival status of patients were extracted. The outcomes were 3-and 5-year survival of CC. Univariate and multivariate Cox regression analyses were used to screen the predictors to develop the predictive nomogram. Internal validation and stratified analyses were further assessed the nomogram. The C-index and area under the curve (AUC) were calculated to estimate the model's predictive capacity, and calibration curves were adopted to estimate the model fit.Results: Totally 38,522 (34.02%) patients died during the 5-year follow-up. The nomogram incorporated variables associated with the prognosis of CC patients, including age, gender, marital status, insurance status, tumor grade, stage (T/N/M), surgery, and number of nodes examined, with a C-index of 0.775 in the training set and 0.774 in the testing set. The AUCs of the nomogram for the 3-and 5-year survival prediction in the training set were 0.817 and 0.808, with the sensitivity of 0.688 and 0.716, and the specificity of 0.785 and 0.740, respectively. Similar results were found in the testing set. The C-index of the predictive nomogram for male, female, White, Black, and other races was 0.769, 0.779, 0.773, 0.770, and 0.770, respectively. The calibration curves for the nomogram in the above five cohorts showed a good agreement between actual and predicted values.Conclusions: The nomogram may exhibit a certain predictive performance based on the SEER database, which may provide individual survival predictions for CC patients.
引用
收藏
页码:2393 / 2405
页数:13
相关论文
共 34 条
[1]   Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J].
Allemani, Claudia ;
Matsuda, Tomohiro ;
Di Carlo, Veronica ;
Harewood, Rhea ;
Matz, Melissa ;
Niksic, Maja ;
Bonaventure, Audrey ;
Valkov, Mikhail ;
Johnson, Christopher J. ;
Esteve, Jacques ;
Ogunbiyi, Olufemi J. ;
Azevedo e Silva, Gulnar ;
Chen, Wan-Qing ;
Eser, Sultan ;
Engholm, Gerda ;
Stiller, Charles A. ;
Monnereau, Alain ;
Woods, Ryan R. ;
Visser, Otto ;
Lim, Gek Hsiang ;
Aitken, Joanne ;
Weir, Hannah K. ;
Coleman, Michel P. .
LANCET, 2018, 391 (10125) :1023-1075
[2]   Updated Review of Major Cancer Risk Factors and Screening Test Use in the United States in 2018 and 2019, with a Focus on Smoking Cessation [J].
Bandi, Priti ;
Minihan, Adair K. ;
Siegel, Rebecca L. ;
Islami, Farhad ;
Nargis, Nigar ;
Jemal, Ahmedin ;
Fedewa, Stacey A. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (07) :1287-1299
[3]   Marital status and stage of cancer at diagnosis: A systematic review [J].
Buja, A. ;
Lago, L. ;
Lago, S. ;
Vinelli, A. ;
Zanardo, C. ;
Baldo, V. .
EUROPEAN JOURNAL OF CANCER CARE, 2018, 27 (01)
[4]   Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence [J].
Burdy, G ;
Panis, Y ;
Alves, A ;
Nemeth, J ;
Lavergne-Slove, A ;
Valleur, P .
DISEASES OF THE COLON & RECTUM, 2001, 44 (11) :1682-1688
[5]   Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer [J].
Cai, Hua-Jun ;
Zhuang, Zhi-Cheng ;
Wu, Yong ;
Zhang, Yi-Yi ;
Liu, Xing ;
Zhuang, Jin-Fu ;
Yang, Yuan-Feng ;
Gao, Yuan ;
Chen, Bin ;
Guan, Guo-Xian .
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (05) :569-576
[6]  
cancer, KEY STAT
[7]   Development and validation of a five-immune gene prognostic risk model in colon cancer [J].
Chen, Haitao ;
Luo, Jun ;
Guo, Jianchun .
BMC CANCER, 2020, 20 (01)
[8]   Association of Cumulative Social Risk and Social Support With Receipt of Chemotherapy Among Patients With Advanced Colorectal Cancer [J].
Davis, Rachel E. ;
Trickey, Amber W. ;
Abrahamse, Paul ;
Kato, Ikuko ;
Ward, Kevin ;
Morris, Arden M. .
JAMA NETWORK OPEN, 2021, 4 (06)
[9]   Comparison of Prognosis and Lymph Node Metastasis in T1-Stage Colonic and Rectal Carcinoma: A Retrospective Study [J].
Deng, Jun ;
Zhou, Shifa ;
Wang, Zhiwen ;
Huang, Genbo ;
Zeng, Jingjun ;
Li, Xiujiang .
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 :3651-3662
[10]   Association of tumor size with prognosis in colon cancer: A Surveillance, Epidemiology, and End Results (SEER) database analysis [J].
Feng, Huolun ;
Lyu, Zejian ;
Zheng, Jiabin ;
Zheng, Chengbin ;
Wu, De Qing ;
Liang, Weijun ;
Li, Yong .
SURGERY, 2021, 169 (05) :1116-1123